Pfizer

Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-partnered I/O drug
Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-partnered I/O drug
Endpoints
Pfizer
PD-L1
cancer
immuno-oncology
Flag link:
Pfizer once again takes out the budget ax and lops off 150 R&D staffers and 5 preclinical biosimilar drugs
Pfizer once again takes out the budget ax and lops off 150 R&D staffers and 5 preclinical biosimilar drugs
Endpoints
Pfizer
R&D
biosimilars
layoffs
Flag link:
FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease
FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease
CP Wire
Pfizer
ATTR
transthyretin amyloid cardiomyopathy
tafamidis
Flag link:
FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease
Pfizer
ATTR
transthyretin amyloid cardiomyopathy
tafamidis
Flag link:
NASH Space in Focus in 2019 as Firms Look to Diversify
NASH Space in Focus in 2019 as Firms Look to Diversify
Yahoo/Zacks.com
NASH
Gilead Sciences
Merck
Roche
Novartis
Jecure Therapeutics
Pfizer
Celgene
Eli Lilly
Flag link:
Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs
Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs
Fierce Pharma
JPMHC 2019
M&A
Pfizer
Biogen
Amarin
Flag link:
JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
CNBC
JNJ
Pfizer
Eli Lilly
Jamie Dimon
Amazon
JPMHC 2019
Flag link:
Takeda’s Shire takeover could herald new era of pharma M&A
Takeda’s Shire takeover could herald new era of pharma M&A
Pharmaforum
M&A
Takeda
Shire
taxes
Pfizer
Flag link:
3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear
3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear
Motley Fool
Pfizer
Albert Bourla
Pharma CEOs
JPMHC 2019
Flag link:
After Pfizer, Sanofi becomes partner of German biotech BioNTech
After Pfizer, Sanofi becomes partner of German biotech BioNTech
GoinPharma
Sanofi
Pfizer
BioNTech
solid tumors
Flag link:
Pfizer begins phase 2b/3 trial of PF-06651600 to treat alopecia areata
Pfizer begins phase 2b/3 trial of PF-06651600 to treat alopecia areata
Pharmaceutical Business Review
Pfizer
clinical trials
PF-06651600
JAK3 inhibitors
alopecia areata
Flag link:
Pfizer, Merck shares smoking hot in 2018 despite doldrums for overall biopharma sector
Pfizer, Merck shares smoking hot in 2018 despite doldrums for overall biopharma sector
Fierce Pharma
oncology
Merck
Pfizer
Flag link:
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Fierce Pharma
Portola Pharmaceuticals
AndexXa
Pfizer
Bristol-Myers Squibb
JNJ
Bayer
FDA
anticoagulant reversal
Flag link:
Report: Pharma companies kick off new year with price hikes
Report: Pharma companies kick off new year with price hikes
Drug Delivery Business News
Allergan
Bristol-Myers Squibb
Biogen
Pfizer
drug pricing
Flag link:
Does Pfizer Have A Multibillion-Dollar Replacement For Opioids?
Does Pfizer Have A Multibillion-Dollar Replacement For Opioids?
Investors Business Daily
Pfizer
Eli Lilly
tanezumab
painkillers
opioids
Flag link:
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
Flag link:
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
CP Wire
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Flag link:
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Flag link:
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Flag link:
Pfizer and GSK Spin off Consumer Health Divisions Into a New Joint Venture
Pfizer and GSK Spin off Consumer Health Divisions Into a New Joint Venture
BioSpace
Pfizer
GSK
M&A
spinoffs
consumer health
Flag link:

Pages